Skip to content
GERICLINICS

GeriQBank · Topic

Cardiovascular Medicine

Hypertension, heart failure, arrhythmias, ischaemic heart disease and thromboembolism.

Questions
71
High-yield
8
Set twice or more
Times set
46
Papers III–IV, 2009–2025
Completed in Cardiovascular Medicine—

Very High Yield(4)

Set 3 or more times

  1. Paper III15-mark essay + 7-mark note

    Cardiomyopathy (short note)

    Definition: structural and functional myocardial disease in the absence of coronary, hypertensive, valvular or congenital disease sufficient to explain it. Five phenotypes (2023 ESC): dilated, hypertrophic, restrictive, arrhythmogenic…

    Very High YieldAsked ×3
  2. Paper III15-mark essay + 7-mark note

    Dilated cardiomyopathy

    Definition: left ventricular or biventricular dilatation with systolic dysfunction not explained by abnormal loading conditions or coronary artery disease. Epidemiology: Pathy's notes that idiopathic dilated cardiomyopathy is relatively…

    Very High YieldAsked ×3

High Yield(4)

Set twice

  1. Paper III7-mark note

    Isolated systolic hypertension and its management

    Isolated systolic hypertension (ISH) = systolic BP ≥140 mmHg with diastolic BP <90 mmHg. Widened pulse pressure is the hallmark. It is the dominant pattern of hypertension in old age. NHANES III showed that fewer than 20% of…

    High YieldAsked ×2
  2. Paper III7-mark note

    Causes, treatment and prevention of deep vein thrombosis

    Deep vein thrombosis (DVT) is thrombus formation within the deep venous system, most often of the lower limb; proximal (popliteal and above) DVT carries the greatest risk of pulmonary embolism and of post-thrombotic syndrome. Venous…

    High YieldAsked ×2
  3. Paper IV15-mark essay

    Management of ST-Elevation Myocardial Infarction and Recent Advances

    STEMI is an acute coronary syndrome caused by complete thrombotic occlusion of a coronary artery following plaque rupture or erosion — a Type 1 myocardial infarction. Diagnosis rests on three things: clinical presentation, ST-segment…

    High YieldAsked ×2
  4. Paper IV7-mark note

    Lifestyle Modification to Reduce Cardiovascular Risk

    Compliance with healthy lifestyle recommendations reduced mortality and the prevalence of chronic disease in a cohort of people aged 65–98 years — the benefits of prevention apply regardless of age or number of risk factors. Standard…

    High YieldAsked ×2

Moderate Yield(31)

Set once

  1. Paper II15-mark essay

    Unstable angina — clinical features, evaluation and management

    Definition and place in the ACS spectrum. Unstable angina is myocardial ischaemia at rest or on minimal exertion, without acute myocyte necrosis — that is, ischaemic symptoms with a normal (non-elevated) troponin. It sits between stable…

    Moderate YieldAsked ×1set in Paper IV
  2. Paper II7-mark note

    Statins in the very old — primary and secondary prevention

    Rationale. Atherosclerotic cardiovascular disease is the leading cause of death and disability in adults aged 75 and above, and age is the strongest single predictor of cardiovascular risk. Because absolute risk rises steeply with age,…

    Moderate YieldAsked ×1set in Paper IV
  3. Paper III6-mark note

    Lacunar Infarcts

    Lacunar Infarcts Definition and pathology Lacunes are small infarcts resulting from occlusion of the small perforating arterioles supplying the basal ganglia, external and internal capsule, thalamus and pons. On brain imaging they are…

    Moderate YieldAsked ×1
  4. Paper III20-mark essay

    Management of hypertension in the elderly

    Hypertension in older people is defined by the same thresholds as in the young, but the pattern differs: systolic BP rises with age while diastolic BP plateaus or falls after about 60 years. Prevalence rises steeply with age. In India,…

    Moderate YieldAsked ×1
  5. Paper III7-mark note

    Congestive heart failure — diagnostic evaluation

    Why it is difficult in the elderly: atypical presentation, multiple comorbidities that mimic HF (COPD, obesity, anaemia, venous stasis, renal disease), and cognitive impairment limiting history-taking. Essentials stresses that HF is…

    Moderate YieldAsked ×1
  6. Paper III7-mark note

    Refractory cardiac failure

    Definition: persistent symptoms of heart failure at rest or on minimal exertion (NYHA class IV) with recurrent congestion or low output, despite maximal tolerated guideline-directed therapy — corresponds to ACC/AHA Stage D, advanced…

    Moderate YieldAsked ×1
  7. Paper III7-mark note

    Diastolic dysfunction

    Definition: impaired ventricular relaxation and/or increased chamber stiffness causing raised filling pressures at normal or near-normal ejection fraction. When symptomatic it manifests as heart failure with preserved ejection fraction…

    Moderate YieldAsked ×1
  8. Paper III7-mark note

    Atrial fibrillation and its management

    Atrial fibrillation (AF) is uncoordinated atrial electrical activation with loss of effective atrial mechanical function — the commonest sustained arrhythmia in older people. Prevalence rises from <0.5% at age 40–50 to 5–15% at age 80.…

    Moderate YieldAsked ×1
  9. Paper III7-mark note

    Sick sinus syndrome

    Definition: Sick sinus syndrome (sinus node dysfunction) is a constellation of electrocardiographic abnormalities — sinus bradycardia, chronotropic incompetence (inadequate sinus response to exercise), sinoatrial exit block, and sinus…

    Moderate YieldAsked ×1
  10. Paper III6-mark note

    Cardiac pacemaker

    Purpose: a permanent pacemaker delivers electrical stimuli to maintain an adequate heart rate and, where possible, atrioventricular synchrony, in symptomatic bradyarrhythmia. Nomenclature (NBG code): position 1 = chamber paced, 2 =…

    Moderate YieldAsked ×1
  11. Paper III7-mark note

    Infective endocarditis

    Infective endocarditis (IE) is microbial infection of the endocardial surface of the heart, typically involving native or prosthetic valves or intracardiac devices, with vegetation as the characteristic lesion. Nearly 50% of all cases…

    Moderate YieldAsked ×1
  12. Paper III7-mark note

    Use of statins in the elderly

    Mechanism: statins inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis and upregulating LDL receptors. Beyond LDL lowering they have pleiotropic effects — plaque stabilisation, reduced inflammation and improved endothelial…

    Moderate YieldAsked ×1
  13. Paper III6-mark note

    Calcium channel antagonists

    Mechanism: calcium channel antagonists block L-type voltage-gated calcium channels, reducing calcium entry into vascular smooth muscle (vasodilatation) and into cardiac myocytes and nodal tissue (negative inotropy and negative…

    Moderate YieldAsked ×1
  14. Paper III7-mark note

    Anticoagulants in geriatric practice — indications and agents

    Both the risk of thrombosis and the risk of haemorrhage increase with age. Older patients therefore stand to gain the most from anticoagulation and to lose the most from it — the central tension of geriatric prescribing. Guidelines are…

    Moderate YieldAsked ×1
  15. Paper IV7-mark note

    Thrombolysis in Stroke

    Thrombolysis in Stroke Fifteen–Twenty High-Yield Points Principle The introduction of intravenous alteplase (rt-PA) transformed acute stroke care. Its benefit is tempered by the risk of precipitating intracranial haemorrhage and by…

    Moderate YieldAsked ×1
  16. Paper IV7-mark note

    Etiopathogenesis and Management of In-Stent Restenosis

    Note: In-stent restenosis is discussed only briefly in Pathy’s (in the context of DES superiority over BMS). The detailed mechanisms and management below are therefore drawn from current peer-reviewed cardiology literature and…

    Moderate YieldAsked ×1
  17. Paper IV7-mark note

    AHA Guidelines for Stroke Prevention in Atrial Fibrillation

    Atrial fibrillation (AF) is the commonest sustained arrhythmia in older people and is a major cause of cardioembolic stroke, heart failure, and death. Stroke in AF arises mainly from thrombus in the left atrial appendage (LAA) — hence…

    Moderate YieldAsked ×1
  18. Paper IV7-mark note

    CHA2DS2-VASc Score — Use and Clinical Significance

    CHA2DS2-VASc is a clinical risk-stratification score that estimates the annual risk of ischaemic stroke and systemic embolism in patients with non-valvular atrial fibrillation. It was developed to refine the earlier CHADS2 score, which…

    Moderate YieldAsked ×1
  19. Paper IV7-mark note

    Causes of Secondary Hypertension — Evaluation and Treatment

    Secondary hypertension is high blood pressure due to an identifiable and often correctable underlying cause. It is uncommon in older adults overall, but should be actively considered in treatment-resistant hypertension and in those with…

    Moderate YieldAsked ×1
  20. Paper IV6-mark note

    Complete Heart Block

    Complete (third-degree) heart block is a total failure of conduction between the atria and the ventricles, resulting in regular atrial activity with an independent ventricular escape rhythm — atrioventricular dissociation. The escape…

    Moderate YieldAsked ×1
  21. Paper IV7-mark note

    Statins in the Elderly

    Statins are HMG-CoA reductase inhibitors — they block the rate-limiting step of hepatic cholesterol synthesis, upregulate LDL receptors, and lower LDL-C by 20–55%. Pleiotropic effects matter as much as lipid lowering: statins stabilise…

    Moderate YieldAsked ×1
  22. Paper IV7-mark note

    Role of Newer Anticoagulants

    Direct oral anticoagulants (DOACs) comprise a direct thrombin (factor IIa) inhibitor — dabigatran — and direct factor Xa inhibitors — apixaban, rivaroxaban, and edoxaban. They act directly on their target enzyme, unlike warfarin (which…

    Moderate YieldAsked ×1
  23. Paper III7-mark note

    Rise and fall of cardiac markers after acute coronary syndrome

    When heart muscle cells die, their proteins leak into the blood. Each marker appears, peaks and clears at its own pace, depending on its size, where it sits in the cell and how it is cleared. Myocardial infarction is now diagnosed by a…

    Moderate YieldAsked ×1

Not rated(32)

No university frequency data yet

  1. Paper II

    Management of refractory heart failure

    Definition. Refractory (advanced or stage D) heart failure is persistent severe symptoms at rest or on minimal exertion (NYHA class III–IV) despite optimal guideline-directed medical and device therapy, with objective severe cardiac…

    Not rated
  2. Paper II

    Role of beta blockers in heart failure

    Rationale and mechanism. Chronic heart failure activates the sympathetic nervous system, which is initially compensatory but ultimately causes myocyte toxicity and apoptosis, adverse remodelling, arrhythmia, down-regulation of β…

    Not rated
  3. Paper II

    Cardiorenal syndrome

    Definition. Cardiorenal syndrome (CRS) is a group of disorders of the heart and kidneys in which acute or chronic dysfunction of one organ induces acute or chronic dysfunction of the other. It is bidirectional, and its recognition…

    Not rated
  4. Paper II

    Drug-eluting stents and in-stent restenosis

    Stent types. A bare-metal stent (BMS) is a bare metallic scaffold that prevents acute recoil but has a high restenosis rate of 20–30%. A drug-eluting stent (DES) has three components — a metal platform, an antiproliferative drug and a…

    Not rated
  5. Paper II

    Atherosclerosis and the biomarkers associated with it

    Definition and burden. Atherosclerotic cardiovascular disease is the leading cause of death and disability in adults aged 75 and older. Atherosclerosis is a slow-developing chronic inflammatory disease that begins as early as the first…

    Not rated
  6. Paper II

    Accelerated hypertension

    Definitions and terminology. Accelerated hypertension is a severe elevation of blood pressure (usually diastolic > 120–130 mmHg) with grade III retinopathy — flame haemorrhages, cotton-wool spots and hard exudates. Malignant…

    Not rated
  7. Paper II

    Aortic sclerosis

    Definition. Aortic sclerosis is focal thickening, fibrosis and calcification of the aortic valve leaflets WITHOUT significant obstruction to left ventricular outflow — by convention a peak transvalvular velocity below 2.5 m/s with…

    Not rated
  8. Paper II

    Mitral regurgitation in the elderly

    Definition and classification. Mitral regurgitation (MR) is systolic backflow from the left ventricle into the left atrium through an incompetent mitral valve. Classify as PRIMARY (degenerative/organic) — a structural abnormality of the…

    Not rated
  9. Paper II

    Infective endocarditis in the elderly

    Definition and burden. Infective endocarditis (IE) is infection of the endocardium, usually of the heart valves. In people over 65 the incidence is about four times that of the general population and mortality is about twice that of…

    Not rated
  10. Paper II

    Cardiomyopathies — classification and management

    Source note: Cardiomyopathy is not covered adequately as a standalone topic in the uploaded textbook (Pathy's refers to dilated and hypertrophic cardiomyopathy mainly as causes of sudden cardiac death; Essentials of Clinical Geriatrics…

    Not rated
  11. Paper II

    Complete heart block and pacemaker indications

    Definition. Third-degree (complete) heart block is complete failure of conduction between atria and ventricles, producing regular atrial activity with an independent escape rhythm. The escape is usually ventricular — wide QRS at 30–40…

    Not rated
  12. Paper II

    Sick sinus syndrome

    Definition. Sick sinus syndrome (sinus node dysfunction) is a spectrum of inappropriate sinus bradycardia, sinus arrest or pause, sinoatrial exit block, chronotropic incompetence, and tachycardia–bradycardia syndrome. Dysfunction may…

    Not rated
  13. Paper II

    Atrial fibrillation

    Definition and epidemiology. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, characterised by uncoordinated atrial activation with consequent loss of atrial mechanical function. It is now regarded as a…

    Not rated
  14. Paper II

    CHA2DS2-VASc and HAS-BLED scores in atrial fibrillation

    Purpose. CHA DS -VASc estimates the annual risk of ischaemic stroke and systemic thromboembolism in non-2 2 valvular atrial fibrillation and decides who needs oral anticoagulation. HAS-BLED estimates major bleeding risk on…

    Not rated
  15. Paper II

    Tachyarrhythmias

    Definition and classification. A tachyarrhythmia is a rhythm with a ventricular rate above 100 beats per minute. Classify first by QRS width — this is the practical bedside division: Narrow complex (QRS < 120 ms) — supraventricular…

    Not rated
  16. Paper II

    Head-up tilt test — indication, procedure and interpretation

    Principle. Head-up tilt testing reproduces the haemodynamic stress of standing under controlled, monitored conditions. Passive upright tilt causes venous pooling of about 500–800 mL of blood in the lower limbs and splanchnic bed,…

    Not rated
  17. Paper II

    Drop attacks

    Definition. A drop attack is a sudden, unexpected fall to the ground WITHOUT loss of consciousness and without warning (no prodrome), with preserved awareness throughout, occurring in the absence of dizziness or vertigo. The patient…

    Not rated
  18. Paper II

    Direct oral anticoagulants — choice, dosing and reversal

    Drugs and mechanism. Dabigatran is a direct thrombin (factor IIa) inhibitor. Rivaroxaban, apixaban and edoxaban are direct factor Xa inhibitors. Advantages over warfarin: predictable pharmacokinetics, no routine monitoring, rapid onset…

    Not rated
  19. Paper II

    Deep vein thrombosis — prophylaxis and treatment

    Risk factors (Virchow's triad). Stasis — immobility, hospitalisation, stroke with hemiplegia, long travel, heart failure. Endothelial injury — surgery, especially hip fracture and hip or knee arthroplasty, trauma, central venous…

    Not rated
  20. Paper II

    Polypill

    Concept and definition. The polypill is a fixed-dose combination tablet containing several cardiovascular drugs, taken once daily, designed to deliver comprehensive cardiovascular risk reduction in a single pill. The concept was…

    Not rated